AzTrials
AzTrials

Iron-deficiencyNCT03835377

Iron-Biofortified Beans Intervention in Mexico

A study testing Iron-biofortified beans in people with Iron-deficiency and Anemia, run by Cornell University at 1 site in Mexico.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this cluster-randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to control beans (Control-Beans). Read more about this study

Who is it for?
Ages 5 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Iron-deficiency, Anemia
What is being tested?
Iron-biofortified beans
Could I receive a placebo?
No, everyone receives an active treatment
How many people
574 participants
Where
1 siteMexico
Study dates
6 Jan 2010to 15 Aug 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Boarding schools for children (5-12 y)
  • Located in a rural area approximately 60 kilometers east of the city of Oaxaca
  • A high prevalence of anemia (>=15.0%) on the baseline survey
  • Adequate infrastructure to sustain a 6-month feeding trial. Exclusion criteria were a prevalence of anemia of less than 15% on the baseline survey, and inadequate infrastructure to sustain a 6-month feeding trial

Who cannot join

  • A prevalence of anemia <15.0% on the baseline survey
  • Inadequate infrastructure to sustain a 6-month feeding trial

Trial locations and contacts

1 site in 1 country.

Mexico1 site
  • Instituto Nacional de Salud Publica (INSP)

    Cuernavaca, Morelos

Other trials in Mexico

About this study

Official title: A Randomized Feeding Trial of Iron-Biofortified Beans in School Children in Mexico

The objective of this cluster-randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to control beans (Control-Beans). A cluster-randomized trial of biofortified beans (Phaseolus vulgaris L), bred to enhance iron content, was conducted for 6 months.

Read the detailed description

Iron deficiency is the most common single nutrient deficiency worldwide, with the highest burden in children and women of reproductive age. Global estimates of anemia prevalence in school-aged children range between 25% and 46%, and iron deficiency accounts for a majority of anemia cases. In Mexico, the national nutrition and health survey (2006) reported a prevalence of anemia of 16.6% and iron deficiency of 17.6% (serum ferritin <12.0 µg/L), posing a considerable health risk for children.

Interventions, including micronutrient supplementation and food fortification, have improved iron status and reduced the prevalence of anemia in some settings. However, iron deficiency remains an urgent public health problem and threat to child health and development. Young children are particularly at high risk due to rapid growth, inadequate dietary intake, and high risk of infection in resource-limited settings. Iron deficiency has been associated with impaired cognitive function in children, and long-term impairments in physical work capacity into adulthood.

One novel approach to reducing micronutrient malnutrition is to enhance the nutrient quality of the diet through biofortification of staple crops that are already locally accepted and consumed. Biofortification has consequently been recognized by the Copenhagen Consensus of 2008 as one of the top five solutions to current global health and nutrition challenges. The success and challenges of biofortification have been documented previously. We recently reviewed the published evidence from the three randomized efficacy trials of different iron-biofortified crops that demonstrated varied benefits in populations, including rice in adult Filipino women, pearl millet in school-aged children in India, and beans in women of reproductive age in Rwanda. Findings demonstrated improvements in serum ferritin concentrations and total body iron concentrations, with additional potential to benefit in individuals who were iron deficient at baseline. Given this limited evidence and with no studies from Latin America, more studies with diverse populations and locally relevant crops are warranted before implementation of a potentially important public health intervention.

In order to target at-risk populations in Latin America, the Centro Internacional de Agricultura Tropical (CIAT) in Colombia bred and biofortified a common black bean variety (Phaseolus vulgaris L), the standard black bean currently consumed widely in Central America and Mexico. In Mexico, beans have been ranked highly among the most consumed foods by school-aged children nationwide, according to Encuesta Nacional de Salud y Nutrición, a nationally representative nutrition survey in 2006. Biofortification has nearly doubled the iron concentration (~100 versus ~50 mg/kg) of the standard bean variety. We hypothesized that daily consumption of iron-biofortified beans (Fe-Beans) would improve hemoglobin, serum ferritin, and total body iron in 6 months, compared to control beans (Control-Beans). In order to examine this hypothesis, we conducted the first randomized efficacy trial of iron-biofortified beans and iron status in primary school-aged children in a low-income setting in Mexico. Special consideration was applied to assess indicators of iron status with and without anemia and measured inflammatory markers, which can mask iron deficiency, particularly in similar settings where the prevalence of infection is high.

The objective of this cluster-randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to control beans (Control-Beans).

The long-term goal of this study is to determine if iron bio-fortification of beans is an efficacious and potentially effective strategy to improve iron status of at-risk populations in resource-limited settings.

Being tested
Iron-biofortified beans, Control beans
Keywords
Iron, Biofortification, Iron deficiency, Anemia, Children, Mexico
Medical subject headings
Anemia, Iron-Deficiency, Anemia, Iron Deficiencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Iron-biofortified beansOther

    Also called Fe-Beans

    Iron-biofortified beans (Phaseolus vulgaris L MIB465)

  • Control beansOther

    Also called Control-Beans

    Control beans (Phaseolus vulgaris L Jamapa variety), identical in color and size

Study groups in NCT03835377
Study groupRoleWhat they receive
Iron-biofortified beansExperimentalIron-biofortified beans (Phaseolus vulgaris L MIB465)
Receives: Other: Iron-biofortified beans
Control beansActive comparatorControl beans (Phaseolus vulgaris L Jamapa variety)
Receives: Other: Control beans

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in hemoglobin

    Hemoglobin (Hb)

    Measured: 6 months

  2. Change in serum ferritin

    Serum ferritin (SF)

    Measured: 6 months

  3. Change in sTfR

    Soluble transferrin receptor (sTfR)

    Measured: 6 months

  4. Anemia

    Hb <115 g/L for <12 y; <120 g/L for >=12 y

    Measured: 6 months

  5. Iron deficiency (SF)

    Serum ferritin <15.0 µg/L

    Measured: 6 months

Secondary outcomes (3)
  1. Change in TBI

    Total body iron (TBI)

    Measured: 6 months

  2. Iron deficiency (TBI)

    TBI <0.0 mg/kg

    Measured: 6 months

  3. Iron deficiency (sTfr)

    sTfr >8.3 μg/mL

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2019
  2. Study start6 Jan 2010
  3. Primary completion25 Jun 2010
  4. Study completion15 Aug 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
574 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03835377
Sponsor's protocol ID
CI-441
Status last verified
Feb 2019
First submitted
11 Jan 2019
Last updated
19 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Finkelstein JL, Mehta S, Villalpando S, Mundo-Rosas V, Luna SV, Rahn M, Shamah-Levy T, Beebe SE, Haas JD. A Randomized Feeding Trial of Iron-Biofortified Beans on School Children in Mexico. Nutrients. 2019 Feb 12;11(2):381. doi: 10.3390/nu11020381.

    PubMed 30759887

Questions about this trial

What is this clinical trial studying?

A study testing Iron-biofortified beans in people with Iron-deficiency and Anemia, run by Cornell University at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in hemoglobin (time frame: 6 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03835377, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in